BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18432524)

  • 21. Hydroxyurea induced oscillations in twelve patients with polycythemia vera.
    Tauscher J; Siegel F; Petrides PE
    Haematologica; 2010 Jul; 95(7):1227-9. PubMed ID: 20220068
    [No Abstract]   [Full Text] [Related]  

  • 22. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
    Fruchtman SM; Mack K; Kaplan ME; Peterson P; Berk PD; Wasserman LR
    Semin Hematol; 1997 Jan; 34(1):17-23. PubMed ID: 9025158
    [No Abstract]   [Full Text] [Related]  

  • 23. Pseudohyperkalaemia in thrombocythaemia.
    Wulkan RW; Michiels JJ
    J Clin Chem Clin Biochem; 1990 Jul; 28(7):489-91. PubMed ID: 2230668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of polycythemia vera with hydroxyurea.
    Tatarsky I; Sharon R
    Semin Hematol; 1997 Jan; 34(1):24-8. PubMed ID: 9025159
    [No Abstract]   [Full Text] [Related]  

  • 25. Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide.
    Harrison CN; Griesshammer M; Miller C; Masszi T; Passamonti F; Zachee P; Durrant S; Pane F; Guglielmelli P; Verstovsek S; Jones MM; Hunter DS; Sun W; Li J; Khan M; Habr D; Kiladjian JJ
    Br J Haematol; 2018 Jul; 182(2):279-284. PubMed ID: 29984424
    [No Abstract]   [Full Text] [Related]  

  • 26. Painful leg ulcers and a rash in a patient with polycythaemia rubra vera. Diagnosis: hydroxyurea-induced leg ulceration and dermatomyositis-like skin changes.
    Haniffa MA; Speight EL
    Clin Exp Dermatol; 2006 Sep; 31(5):733-4. PubMed ID: 16901329
    [No Abstract]   [Full Text] [Related]  

  • 27. Qualitative platelet defect and thrombohaemorrhagic complications in a patient with polycythaemia vera. Case 10.
    Friess D; Lämmle B; Alberio L
    Hamostaseologie; 2003 Aug; 23(3):138-43. PubMed ID: 12923585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An unusual case of toe ulceration.
    Lankipalli R; Konkle B; Mohler ER
    Vasc Med; 2006 Feb; 11(1):35-7. PubMed ID: 16669411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of hydroxyurea-induced longitudinal melanonychia.
    Utaş S; Kulluk P
    Int J Dermatol; 2010 Apr; 49(4):469-70. PubMed ID: 20465711
    [No Abstract]   [Full Text] [Related]  

  • 30. Soluble CD40 ligand and endothelial dysfunction in aspirin-treated polycythaemia vera patients.
    Lessiani G; Dragani A; Falco A; Fioritoni F; Santilli F; Davì G
    Br J Haematol; 2009 May; 145(4):538-40. PubMed ID: 19298588
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hydroxyurea in the treatment of erythremia].
    Demidova AV
    Ter Arkh; 1993; 65(9):82-4. PubMed ID: 8303607
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased platelet glycoprotein Ib receptor number, enhanced platelet adhesion and severe cerebral ischaemia in a patient with polycythaemia vera.
    Toth J; Kappelmayer J; Udvardy ML; Szanto T; Szarvas M; Rejto L; Soltesz P; Udvardy M; Harsfalvi J
    Platelets; 2009 Jun; 20(4):282-7. PubMed ID: 19459135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Polycythemia vera--focus on the Hb value. Future treatment can maybe result in disease remission].
    Johansson P; Andreasson B; Samuelsson J
    Lakartidningen; 2009 Jan 14-20; 106(3):104-9. PubMed ID: 19248459
    [No Abstract]   [Full Text] [Related]  

  • 34. [Black discoloration of nails in polycythaemia vera].
    Konrad H; Wollina U
    J Dtsch Dermatol Ges; 2005 Sep; 3(9):723-5. PubMed ID: 16173981
    [No Abstract]   [Full Text] [Related]  

  • 35. [Development of skin squamous cell carcinoma on the scalp in a hydroxycarbamide-treated polycythemia vera patient].
    Suzuki M; Maezima E; Ohnuma T; Kawamura T; Kirito K
    Rinsho Ketsueki; 2020; 61(12):1670-1672. PubMed ID: 33441519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.
    Finazzi G; Vannucchi AM; Martinelli V; Ruggeri M; Nobile F; Specchia G; Pogliani EM; Olimpieri OM; Fioritoni G; Musolino C; Cilloni D; Sivera P; Barosi G; Finazzi MC; Tollo SD; Demuth T; Barbui T; Rambaldi A
    Br J Haematol; 2013 Jun; 161(5):688-694. PubMed ID: 23573950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose aspirin in polycythemia vera.
    Denes AE
    N Engl J Med; 2004 Apr; 350(16):1683-5; author reply 1683-5. PubMed ID: 15088323
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment with hydroxyurea of polycythemia vera in a 11 year-old child].
    Vodoff MV; Nelken B; Vic P; Farriaux JP
    Arch Pediatr; 1996 Sep; 3(9):870-3. PubMed ID: 8949347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytostatic treatment of polycythaemia rubra vera. Comparison of the effects of some cytostatics in 100 patients in a period of five years.
    Nagy G; Léhi M
    Haematologia (Budap); 1975; 9(3-4):283-6. PubMed ID: 181298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ruxolitinib (JAKAVI°) and polycythaemia vera Inconclusive evaluation.
    Prescrire Int; 2016 Oct; 25(175):229-231. PubMed ID: 30645821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.